Heat Shock Protein-70 (HSP70) is an Essential Component of Anti-Tumor Immunity

The attached article demonstrates a key role for tumor-derived HSP70 in the development of robust anti-tumor immune responses. The results validate HSP70 as a target for the development of a novel class of immunomodulatory drugs, which is the focus of the Asylia platform.

Published by Oncogene: March 14 2014

Share on facebook
Share on twitter
Share on linkedin
Scroll to Top